Results 181 to 190 of about 172,791 (358)

Treatment of psoriasis. [PDF]

BMJ, 1966
openaire   +3 more sources

Sun Exposure Behaviors of Patients With Moderate‐to‐Severe Psoriasis: Results From the French PSOBIOTEQ Cohort

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Tanning addiction is a behavioral addiction characterized by an irrepressible desire for sun or ultraviolet light exposure. It is thought to affect 10% to 25% of the population. Objectives This study aimed to estimate the prevalence of this behavior in patients with moderate‐to‐severe psoriasis and identify associated factors ...
E. Mahé, R. Curmin, C. Paul, H. Bachelez, M. Beylot‐Barry, N. Beneton, A. Dupuy, P. Joly, D. Jullien, M.‐A. Richard, M. Viguier, E. Sbidian, O. Chosidow, F. Tubach, the PsoBioTeq Study group   +14 more
wiley   +1 more source

Psoriasis--Treatment [PDF]

BMJ, 1971
openaire   +2 more sources

Exploring the Cutaneous Associations of Crohn's Disease: A Retrospective Study of 108 Patients

JEADV Clinical Practice, EarlyView.
ABSTRACT Background The integumentary system provides a window into the overall health of individuals and may display cutaneous manifestations of systemic disease. Crohn's Disease (CD) is a relapsing inflammatory bowel disease that exhibits a significant symptomatic burden on a global scale.
Max E. Oscherwitz, Jose W. Ricardo, Nashali M. Vescovacci, Alysia B. Kohrs, Joseph L. Jorizzo   +4 more
wiley   +1 more source

Successful Treatment of Erythroderma in a Psoriasis Patient, Developed After Anti‐IL‐17, Anti‐IL‐23 and Anti‐IL‐4/IL‐13 Treatment, With Deucravacitinib

JEADV Clinical Practice, EarlyView.
ABSTRACT We present the case of a 79‐year‐old female patient diagnosed with psoriasis who developed paradoxical drug reactions after administration of anti‐IL17 and anti‐IL‐23 inhibitors. Having shifted towards a rather eczematous phenotype, the patient received an anti‐IL‐4/IL‐3 inhibitor, subsequently developing erythroderma.
Tugce Guel, Luka de Vos‐Hillebrand, Dagmar Wilsmann‐Theis, Natalija Novak, Joerg Wenzel   +4 more
wiley   +1 more source

Trends in Systemic Psoriasis Treatment: Is Psoriasis Still Being Undertreated? [PDF]

Ann Dermatol, 2023
Choi S, Oh S, Yoon HS.
europepmc   +1 more source

Genital Psoriasis: Shining Light on This Hidden Disease

JEADV Clinical Practice, EarlyView.
Psoriasis occurring on skin of the genital and perigenital regions has specific diagnostic and treatment requirements due to the sensitivity and private nature of these areas. A multidisciplinary group of experts in the management of genital psoriasis, the Genital Psoriasis Wellness Consortium, convened to discuss the impact of genital psoriasis on ...
Jennifer Cather, Melodie Young, Muriel Boreham, Shehla Admani, Tina Bhutani, Erin Foster, Richard Fried, Melinda Gooderham, Jeannette Jakus, Sandra Johnson, Ryoichi Kamide, John Koo, Tiffany Mayo, Michael Payette, Caitriona Ryan, Lucinda Whitney, Krista Bohnert, Melissa Seal, Patrick Burnett, Diane Hanna   +19 more
wiley   +1 more source

Treatment of psoriasis with oral psoralens and longwave ultraviolet light. Therapeutic results and cytogenetic hazards

, 1975
G Swanbeck, M. Thyresson-Hök, Anders Bredberg, B. Lambert   +3 more
openalex   +2 more sources

Review of natural compounds for potential psoriasis treatment. [PDF]

Inflammopharmacology, 2023
Elkhawaga OY, Ellety MM, Mofty SO, Ghanem MS, Mohamed AO.   +4 more
europepmc   +1 more source

An Animal Model For Screening Topical And Systemic Drugs For Potential Use In The Treatment Of Psoriasis

, 1975
Anthony du Vivier, Richard B. Stoughton
openalex   +1 more source